Covid-19 vaccine could soon be needle-free The AustralianCarolyn MillerJune 3, 2021Vaxxas, Paul Kelly
How Shippit got lean and profitable during COVID The AustralianCarolyn MillerAugust 25, 2020Shippit, Michelle Deaker, Nick Gainsley
Clinical Genomics’ gene-based blood test Colvera a first The AustralianCarolyn MillerJune 1, 2018Clinical Genomics, Paul Kelly
US college admissions test body ACT invests in Smart Sparrow The AustralianCarolyn MillerFebruary 7, 2018Smart Sparrow, Michelle Deaker
Venture capital fund OneVentures looks to boost $100m target The AustralianCarolyn MillerDecember 17, 2015OneVentures, Michelle Deaker
Start-ups must take risk and look outward: VC fund The AustralianCarolyn MillerJuly 20, 2015Amir Zalcenstein
Investors keen on biotech injection: OneVentures The AustralianCarolyn MillerFebruary 11, 2015OneVentures, Paul Kelly, Anne-Marie Birkill, Michelle Deaker
Old world money unites with best and brightest in world of disruption The AustralianCarolyn MillerDecember 20, 2014OneVentures, Michelle Deaker
Hatchtech gets new VC backing for lice treatment trial The AustralianCarolyn MillerNovember 1, 2013Hatchtech, Paul Kelly
